Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

294

Full text

235

Free full text

111

Publication Types

Journal Article

294

Review

147

Research Support, Non-U.S. Gov't

101

Randomized Controlled Trial

Comparative Study

Clinical Trial

Multicenter Study

Systematic Review

Research Support, N.I.H., Extramural

Observational Study

Meta-Analysis

Research Support, U.S. Gov't, Non-P.H.S.

Controlled Clinical Trial

Clinical Trial, Phase II

Case Reports

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase III

Consensus Development Conference

Historical Article

Network Meta-Analysis

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Calcineurin""[mesh_terms]

300 Results

Searching titles within these results

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.

Elizabeth Head, Christopher Norris, Jacob Dohl, Zoe Treadwell

Alzheimer's & dementia : the journal of the Alzheimer's Association 2025;21(3):e70034

Free Full Text

Abstract

Calcineurin-inhibitor pain syndrome.

Eric Prommer

The Clinical journal of pain 2012;28(6):556-9

Full Text

Abstract

Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders.

Haixiang Yu, Theo J C van Berkel, Erik A L Biessen

Cardiovascular drug reviews 2007;25(2):175-87

Full Text

Abstract

Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis.

Teun van Gelder, Edgar Lerma, Kory Engelke, Robert B Huizinga

Expert review of clinical pharmacology 2022;15(5):515-529

Free Full Text

Abstract

Comparing guidelines for the treatment of inflammatory bowel disease.

Joseph B Kirsner, Stephen B Hanauer

Digestive diseases (Basel, Switzerland) 2014;31(3-4):360-2

Full Text

Abstract

Current management of atopic dermatitis and interruption of the atopic march.

Mark Boguniewicz, Lawrence F Eichenfield, Thomas Hultsch

The Journal of allergy and clinical immunology 2004;112(6 Suppl):S140-50

Full Text

Abstract

Calcineurin inhibitors in systemic lupus erythematosus.

Chi Chiu Mok

Best practice & research. Clinical rheumatology 2018;31(3):429-438

Full Text

Abstract

Regulation of NFAT activation: a potential therapeutic target for immunosuppression.

Mina Lee, Jungchan Park

Molecules and cells 2006;22(1):1-7

Free Full Text

Abstract

A comprehensive review of the clinical presentation, diagnosis, and treatment of calcineurin inhibitor-induced pain syndrome.

Muhammad Hamza Shah, Mrinmoy Kundu, Toufik Abdul-Rahman, Athanasios Alexiou, Andrew Awuah Wireko, Ranferi Eduardo Herrera-Calderón, Jann Ludwig Mueller-Gomez, Maximillian Wolfson, Marcos Lisbona-Buzali, Tamara Mena-Guerrero, Andrea Paola Munoz-Villalvazo, Marija Zivcevska, Ogungbemi Evelyn Faith, Ana Luisa Ek, Inibehe Ime Okon

European journal of medical research 2025;30(1):177

Free Full Text

Abstract

Electromagnetic fields may act via calcineurin inhibition to suppress immunity, thereby increasing risk for opportunistic infection: Conceivable mechanisms of action.

O Johansson, P R Doyon

Medical hypotheses 2018;106():71-87

Full Text

Abstract

Potential food-drug interactions in patients with rheumatoid arthritis.

Kayo Masuko, Shigeto Tohma, Toshihiro Matsui

International journal of rheumatic diseases 2014;16(2):122-8

Full Text

Abstract

Investigating the human Calcineurin Interaction Network using the πɸLxVP SLiM.

Sarah R Sheftic, Rebecca Page, Wolfgang Peti

Scientific reports 2018;6():38920

Free Full Text

Abstract

Inhibitors of the calcineurin/NFAT pathway.

Juan Miguel Redondo, Sara Martínez-Martínez

Current medicinal chemistry 2004;11(8):997-1007

Full Text

Abstract

Posttransplantation hypertension related to calcineurin inhibitors.

S C Textor, S J Taler, V J Canzanello, L Schwartz, J E Augustine

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000;6(5):521-30

Free Full Text

Abstract

The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

Samira S Farouk, Joshua L Rein

Advances in chronic kidney disease 2021;27(1):56-66

Free Full Text

Abstract

Results: 1 – 15 / 300

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Calcineurin""[mesh_terms]

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.

Calcineurin-inhibitor pain syndrome.

Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders.

Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis.

Comparing guidelines for the treatment of inflammatory bowel disease.

Current management of atopic dermatitis and interruption of the atopic march.

Calcineurin inhibitors in systemic lupus erythematosus.

Regulation of NFAT activation: a potential therapeutic target for immunosuppression.

A comprehensive review of the clinical presentation, diagnosis, and treatment of calcineurin inhibitor-induced pain syndrome.

Electromagnetic fields may act via calcineurin inhibition to suppress immunity, thereby increasing risk for opportunistic infection: Conceivable mechanisms of action.

Potential food-drug interactions in patients with rheumatoid arthritis.

Investigating the human Calcineurin Interaction Network using the πɸLxVP SLiM.

Inhibitors of the calcineurin/NFAT pathway.

Posttransplantation hypertension related to calcineurin inhibitors.

The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

Results for
""Calcineurin""[mesh_terms]